Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.


Press Release, 17 December 2018

Kuros ends transformational year with first MagnetOs sales, lead clinical program on track, and successful capital raise

Press Release, 13 December 2018

Kuros announces final result of capital increase – total gross proceeds of 16.1 million raised

Press Release, 12 December 2018

Kuros announces results of rights offering – capital increase will be implemented

Press Release, 10 December 2018

Kuros receives FDA 510(k) clearance for extending commercial indications of MagnetOs Putty in the United States

Press Release, 06 December 2018

Kuros reports publication of MagnetOs data demonstrating equivalence to autologous bone in spinal fusion

Press Release, 29 November 2018

Extraordinary General Meeting of Kuros Biosciences approves all resolutions